The medical device market is expected to grow to almost $800 billion by 2030. Here's a list of the year's best opportunities. The United States has a $115.5 billion trade deficit in pharmaceutical ...
GLP-1 medications treat type 2 diabetes and obesity by mimicking a hormone that helps manage blood sugar. A balanced diet can improve how well these medications work. The best foods to eat while on ...
Bekannte Abnehmspritzen und -pillen sind bereits relativ wirksam gegen Übergewicht. Ein neues Mittel übertrifft diese laut Hersteller Eli Lilly jedoch deutlich: Teilnehmer einer Studie verlieren zum T ...
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans think about weight loss. In fact, a recent poll finds 1 in 8 adults are now ...
Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...
Modern medicine is continually advancing treatment options for many chronic health conditions. For type 2 diabetes, obesity, and weight management, GLP-1 receptor agonists are medications that may ...
For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results